Hilab

Hilab, founded in 2004 by Marcus Figueredo, Sergio Rogal, and Carlos Eduardo Chaves, operates as a developer of remote diagnostic systems and devices. The company's genesis is rooted in the founders' academic backgrounds in computer engineering and artificial intelligence. Marcus Figueredo, the CEO, holds a Ph.D. in AI for health, and Sergio Rogal, the CTO, has a Master's degree in Artificial Intelligence with a focus on detecting cardiac arrhythmias. This expertise underpins the company's core mission to democratize healthcare access through technology.

The firm's business revolves around a point-of-care testing (POCT) model, providing portable, IoT-enabled devices that deliver rapid diagnostic results. These mini-laboratories utilize a cloud-based platform and artificial intelligence to analyze samples and generate reports in minutes, a process significantly faster than traditional laboratory testing which can take weeks in remote locations. Hilab's revenue is generated through the provision of these testing services and devices to a diverse client base that includes pharmacies, clinics, hospitals, laboratories, and organizations focused on public and occupational health. The company's financial history includes raising a total of $10 million over three funding rounds, with its latest Series B round in November 2022. Key investors include Endeavor, Peninsula Participacoes, Tech Emerge, Monashees, EB Capital, and Positivo Tecnologia.

Hilab offers a portfolio of compact, multi-methodology devices. The 'Hilab Flow' handles immunochromatography, fluorescence, and colorimetry tests. The 'Hilab Lens' is described as the world's smallest point-of-care Complete Blood Count (CBC) analyzer, providing results from a fingerstick in under 25 minutes. Other devices include the 'Hilab Volt' for electrochemical tests and 'Hilab Molecular' for molecular biology tests analogous to RT-PCR. This suite of products enables a wide range of common tests to be performed outside of a traditional lab setting, enhancing efficiency and patient convenience.

Keywords: point-of-care testing, remote diagnostics, healthtech, medical devices, artificial intelligence in healthcare, digital health, diagnostic technology, laboratory services, telemedicine, IoT healthcare, CBC analyzer, rapid diagnostics, mobile health, immunoassay, molecular diagnostics, healthcare accessibility, occupational health testing, public health surveillance, pharmacy services, clinical diagnostics